Tissue Regenix shares remain suspended ahead of delisting
Tissue Regenix has issued a fresh update as it presses ahead with its planned cancellation of its AIM listing.
The firm says it expects to remain solvent - assuming shareholders green-light resolutions at the general meeting on 22 December and an initial £7.5m tranche of the previously announced Secured Convertible Loan Note is drawn down shortly after.
However, the Leeds-based company conceded it cannot paint a definitive picture of the company’s financial standing ahead of the expected cancellation date of 7 January 2026. A... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
